换一批
换一批Effectiveness of a bivalent mRNA vaccine dose against symptomatic SARS-CoV-2 infection among U.S. Healthcare personnel, September 2022-May 2023.
作者：
Ian D,Plumb [1]
;
Melissa,Briggs Hagen [2]
;
Ryan,Wiegand [2]
;
Ghinwa,Dumyati [3]
;
Christopher,Myers [3]
;
Karisa K,Harland [4]
;
Anusha,Krishnadasan [5]
;
Jade,James Gist [2]
;
Glen,Abedi [2]
;
Katherine E,Fleming-Dutra [2]
;
Nora,Chea [6]
;
Jane E,Lee [7]
;
Melissa,Kellogg [8]
;
Alexandra,Edmundson [9]
;
Amber,Britton [10]
;
Lucy E,Wilson [11]
;
Sara A,Lovett [12]
;
Valerie,Ocampo [13]
;
Tiffanie M,Markus [14]
;
Howard A,Smithline [15]
;
Peter C,Hou [16]
;
Lilly C,Lee [17]
;
William,Mower [18]
;
Fernand,Rwamwejo [19]
;
Mark T,Steele [20]
;
Stephen C,Lim [21]
;
Walter A,Schrading [22]
;
Brian,Chinnock [23]
;
David G,Beiser [24]
;
Brett,Faine [4]
;
John P,Haran [25]
;
Utsav,Nandi [26]
;
Anne K,Chipman [27]
;
Frank,LoVecchio [28]
;
Stephanie,Eucker [29]
;
Jon,Femling [30]
;
Matthew,Fuller [31]
;
Richard E,Rothman [32]
;
Marcel E,Curlin [33]
;
David A,Talan [18]
;
Nicholas M,Mohr [4]
;
Vaccine Effectiveness among Healthcare Personnel Study Team
作者单位：
National Center for Immunizations and Respiratory Diseases, Centers for Disease Control & Prevention, Atlanta, GA, USA. Electronic address: iplumb@cdc.gov.
[1]
National Center for Immunizations and Respiratory Diseases, Centers for Disease Control & Prevention, Atlanta, GA, USA.
[2]
University of Rochester Medical Center, Rochester, NY, USA.
[3]
University of Iowa, Iowa City, IA, USA.
[4]
Olive View- UCLA Education and Research Institute, CA, USA.
[5]
National Center for Emerging and Zoonotic Diseases, Centers for Disease Control & Prevention, USA.
[6]
California Emerging Infections Program, Oakland, CA, USA.
[7]
Colorado Department of Public Health & Environment, CO, USA.
[8]
Connecticut Emerging Infections Program, Yale School of Public Health, CT, USA.
[9]
Georgia Emerging Infections Program and Emory University School of Medicine, Atlanta, GA, USA.
[10]
Maryland Emerging Infections Program, Maryland Department of Health and University of Maryland, Baltimore, MD, USA.
[11]
Minnesota Department of Health, MN, USA.
[12]
Public Health Division, Oregon Health Authority, OR, USA.
[13]
Vanderbilt University Medical Center, Nashville, TN, USA.
[14]
Baystate Medical Center, Springfield, MA, USA.
[15]
Brigham and Women's Hospital, Boston, MA, USA.
[16]
Jackson Memorial Hospital, Miami, FL, USA.
[17]
David Geffen School of Medicine, UCLA, CA, USA.
[18]
Thomas Jefferson University Hospital, Philadelphia, PA, USA.
[19]
University of Missouri-Kansas City, Kansas City, MO, USA.
[20]
University Medical Center New Orleans, LSU Health Sciences Center, New Orleans, LA, USA.
[21]
University of Alabama at Birmingham, Birmingham, AL, USA.
[22]
University of California San Francisco, Fresno, CA, USA.
[23]
University of Chicago, Chicago, IL, USA.
[24]
University of Massachusetts Chan Medical School, Worcester, MA, USA.
[25]
University of Mississippi Medical Center, Jackson, MS, USA.
[26]
University of Washington, Seattle, WA, USA.
[27]
Valleywise Health Medical Center, Phoenix, AZ, USA.
[28]
Duke University School of Medicine, NC, USA.
[29]
University of New Mexico Health Science Center, USA.
[30]
University of Utah School of Medicine, USA.
[31]
Department of Emergency Medicine, Johns Hopkins University, Baltimore, MD, USA.
[32]
Oregon Health and Sciences University, USA.
[33]
主题词
人类(Humans);婴儿, 新生(Infant, Newborn);疫苗, 联合(Vaccines, Combined);病例对照研究(Case-Control Studies);RNA, 信使(RNA, Messenger);卫生保健提供(Delivery of Health Care)
DOI
10.1016/j.vaccine.2023.10.072
PMID
37973512
发布时间
2024-04-09
- 浏览0
Vaccine
Vaccine
2543-2552页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
